Emerging Sequencing Reagents Market Trends: Advancements In Long-Read Sequencing For Human Genome Shaping the Future of the Industry

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Sequencing Reagents Market Size Growth Forecast: What to Expect by 2025?
In recent years, the market size for sequencing reagents has seen a swift increase. It is expected to expand from a value of $10.45 billion in 2024 to $12.21 billion in 2025, with a compound annual growth rate (CAGR) of 16.9%. Several factors account for this historic growth, including the integration of sequencing in the discovery and development of drugs, the encouragement of genomics research via government programs, the rising use of sequencing in clinical diagnosis, a growing occurrence of genetic disorders, and the introduction of precision medicine initiatives.

How Will the Sequencing Reagents Market Size Evolve and Grow by 2029?
In the coming years, the sequencing reagents market is projected to experience swift expansion, reaching a value of $22.5 billion by 2029, growing at a compound annual growth rate (CAGR) of 16.5%. This growth during the forecast period is due to factors such as an increase in cancer genomics research and precision oncology, the development of bioinformatics tools and software for data analysis, a surge in investments in genomics research and healthcare infrastructure, a rising demand for personalized medicine, and the broadening use of sequencing in agriculture and livestock. Key trends for the forecast period involve the creation of portable and benchtop sequencing platforms, amalgamation of sequencing with other omics technologies, the emergence of innovative sequencing reagents for epigenetic analysis, advancements in sequencing technologies, and an uptick in investments in research and development for new sequencing technologies and reagents.

View the full report here:
https://www.thebusinessresearchcompany.com/report/sequencing-reagents-global-market-report

What Drivers Are Propelling the Growth of Sequencing Reagents Market Forward?
Advancements and increasing popularity in personalized medicine are set to stimulate the growth of the sequencing reagents market. Personalized medicine, or precision medicine, is a medical treatment approach that customizes healthcare decisions and treatments according to each patient's unique traits. The escalation in personalized medicine's demand is driven by developments in genomics and molecular diagnostics, facilitating treatment adaptations based on individual genetic mapping and disease attributes. Sequencing reagents are essential in personalized medicine as they enable precise analysis of personal genetic data for individualized diagnostic and therapeutic interventions. For example, the Personalized Medicine Coalition (PMC), a US-based non-profit organization, reported in February 2024 that personalized medicines made up over a third of all new U.S. Food and Drug Administration (FDA) drug approvals for the fourth consecutive year in 2023. Furthermore, in 2023, the FDA gave approval to 16 new personalized treatments for rare disease patients, a significant increase from six in 2022. Hence, the increasing demand and progress in personalized medicine will fuel the sequencing reagents market growth.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16184&type=smp

Which Emerging Trends Are Transforming the Sequencing Reagents Market in 2025?
Key players in the sequencing reagents sector are concentrating on creating cutting-edge innovations like the Illumina Complete Long Read technology to establish themselves as pioneers in this market. Developed as an advanced sequencing technology, Illumina complete long-read technology integrates the precision and throughput of short-read sequencing with the in-depth coverage and potential to deal with complicated genomic regions offered by long-read sequencing. For example, in March 2023, Illumina Inc., a US-based biotech company, unveiled the Illumina Complete Long Read Prep, Human. This efficient, long-read, human whole-genome sequencing (WGS) assay can be used with Illumina NovaSeq X Plus, NovaSeq X, and NovaSeq 6000 Sequencing Systems. The Illumina Complete Long Read Prep for Humans provides a thorough process for long-read sequencing of the human genome on Illumina platforms, encompassing sample handling, library formation, and sequencing. This allows researchers to create long sequencing reads for extensive genomic examinations, including the detection of structural variations and intricate genomic regions.

What Are the Key Segments in the Sequencing Reagents Market?
The sequencing reagents market covered in this report is segmented -

1) By Type: Library Kits, Template Kits, Control Kits, Sequencing Kits, Other Types
2) By Technology: Sanger Sequencing, Next Generation Sequencing, Third Generation Sequencing
3) By Application: Oncology, Reproductive Health, Clinical Investigation, Agrigenomics And Forensics, Other Applications
4) By Industry Verticals: Research Institutes, Hospitals and Clinics, Pharmaceutical And Biotechnology Companies, Other Industry Verticals

Subsegments:
1) By Library Kits: Dna Library Kits, Rna Library Kits, Whole Genome Library Kits, Targeted Sequencing Library Kits, Amplicon Library Kits
2) By Template Kits: Dna Template Kits, Rna Template Kits, Cdna Template Kits, Single-Cell Rna Template Kits
3) By Control Kits: Positive Control Kits, Negative Control Kits, Internal Control Kits, Quality Control Kits
4) By Sequencing Kits: Next-Generation Sequencing (Ngs) Kits, Whole Genome Sequencing Kits, Targeted Sequencing Kits, Exome Sequencing Kits, Rna Sequencing Kits
5) By Other Types: Pcr Reagents And Kits, Cloning Kits, Multiplexing Kits, Sanger Sequencing Reagents

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=16184&type=smp

Who Are the Key Players Shaping the Sequencing Reagents Market's Competitive Landscape?
Major companies operating in the sequencing reagents market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Agilent Technologies Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., BGI Group, Beckman Coulter Inc., Hamilton Company, GenScript Biotech Corporation, Promega Corporation, Integrated DNA Technologies (IDT), BioLegend, Twist Bioscience, Diagenode, Covaris Inc., Oxford Nanopore Technologies plc, Biotage, Takara Bio Inc., New England Biolabs (NEB), Pacific Biosciences of California Inc., Zymo Research, Lucigen Corporation, Norgen Biotek Corp., Lexogen GmbH, Daicel Arbor Biosciences, Swift Biosciences Inc.

What Geographic Markets Are Powering Growth in the Sequencing Reagents Market?
North America was the largest region in the sequencing reagents market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sequencing reagents market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16184

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.